Dr. Reddy’s Laboratories has launched Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg and 40 mg, a therapeutic equivalent generic version of NEXIUM® (esomeprazole magnesium) Delayed-Release Capsules in the US market on September 25, 2015, following the approval by the United States Food & Drug Administration (USFDA).
The NEXIUM® (esomeprazole magnesium) Delayed-Release Capsules brand and generic had U.S. sales of approximately $5.2 Billion MAT for the most recent twelve months ending in July 2015 according to IMS Health*.
Dr. Reddy’s Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg and 40 mg are available in bottle count size of 30.
NEXIUM® is a registered trademark of AstraZeneca AB Corporation